$135.910
+0.788 (+0.58%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Neurocrine Biosciences, Inc (NBIX) Moving Averages Convergence Divergence (MACD) indicator is -3.71, suggesting NBIX is Strong sell.
Neurocrine Biosciences, Inc (NBIX) 20-Day simple moving average is 140.97, while Neurocrine Biosciences, Inc (NBIX) share price is $—, making it Sell.
Neurocrine Biosciences, Inc (NBIX) 60-Day simple moving average is 153.71, while Neurocrine Biosciences, Inc (NBIX) share price is $—, making it Sell.
Technical Analysis for NBIX
AI Technical NBIXAs of 2026-10-10, the technical board for Neurocrine Biosciences, Inc (NBIX) reads strong sell: 2 indicators are flashing buy, 9 are indicating sell, and 2 are neutral. Price at $135.91 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 34.737, MACD stands at -3.711 (Sell), Stochastic %K stands at 18.235 (Buy), Stochastic %D stands at 26.321 and CCI stands at -114.667 (Buy).
NBIX trades below the 60-day SMA (153.71) and below the 200-day SMA (147.06). Immediate resistance sits at Classic R1 147.78, then R2 154.68. Support sits at Classic S1 133.11, then S2 125.35.
Neurocrine Biosciences, Inc (NBIX) Support & Resistance Level
Neurocrine Biosciences, Inc (NBIX) Technical Indicators
2026-10-10
| Name | Value |
|---|---|
| RSI_14 | 34.737 |
| STOCHk_14_3_3 | 18.235 |
| STOCHd_14_3_3 | 26.321 |
| CCI_20 | -114.667 |
| AO_5_34 | -8.364 |
| MOM_10 | -4.390 |
| MACD_12_26_9 | -3.711 |
Neurocrine Biosciences, Inc (NBIX) Relative Strength Index (RSI_14) is 34.737, creating a Neutral signal.
Neurocrine Biosciences, Inc (NBIX) Stochastic %K is 18.235, creating a Buy signal.
Neurocrine Biosciences, Inc (NBIX) Stochastic %D is 26.321, creating a Neutral signal.
Neurocrine Biosciences, Inc (NBIX) CCI_20 is -114.667, creating a Buy signal.
Neurocrine Biosciences, Inc (NBIX) Awesome Oscillator (AO) is -8.364, creating a Sell signal.
Neurocrine Biosciences, Inc (NBIX) Momentum (MOM) is -4.390, creating a Sell signal.
Neurocrine Biosciences, Inc (NBIX) Moving Average Convergence Divergence (MACD) is -3.711, creating a Sell signal.
Neurocrine Biosciences, Inc (NBIX) Moving Average
2026-10-10
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 138.234 | Sell |
| MA_10 | 140.879 | Sell |
| MA_20 | 140.970 | Sell |
| MA_60 | 153.708 | Sell |
| MA_200 | 147.062 | Sell |
| MA_250 | 147.001 | Sell |
Neurocrine Biosciences, Inc (NBIX) 5-Day simple moving average is 138.234, while Neurocrine Biosciences, Inc (NBIX) share price is $, making it a Sell.
Neurocrine Biosciences, Inc (NBIX) 10-Day simple moving average is 140.879, while Neurocrine Biosciences, Inc (NBIX) share price is $, making it a Sell.
Neurocrine Biosciences, Inc (NBIX) 20-Day simple moving average is 140.970, while Neurocrine Biosciences, Inc (NBIX) share price is $, making it a Sell.
Neurocrine Biosciences, Inc (NBIX) 60-Day simple moving average is 153.708, while Neurocrine Biosciences, Inc (NBIX) share price is $, making it a Sell.
Neurocrine Biosciences, Inc (NBIX) 200-Day simple moving average is 147.062, while Neurocrine Biosciences, Inc (NBIX) share price is $, making it a Sell.
Neurocrine Biosciences, Inc (NBIX) 250-Day simple moving average is 147.001, while Neurocrine Biosciences, Inc (NBIX) share price is $, making it a Sell.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.